Bladder Cancer Trial, Recruiting NCT07607990 Sponsor: Zhejiang University Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT07607990
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 80 years old (inclusive)
  • People whose overall health before surgery falls within a certain accepted range, as assessed by an anaesthesiologist (known as ASA Class I–III — confirm with trial site if unsure what this means)
  • People scheduled for a planned (non-emergency) keyhole surgery to remove the prostate, performed under general anaesthetic
  • People who fully understand the study, are willing to take part voluntarily, and have signed a consent form either themselves or through a family member

Who may not be able to join:

  • People who have an existing bladder condition, such as overactive bladder (needing to urinate more than 3 times per night or more than 8 times in 24 hours), a bladder controlled by nerve damage, or a blockage affecting urine flow
  • People who have previously had surgery on pelvic organs or the spine that affects how the bladder works
  • People who have previously had complete surgical removal of the colon and rectum
  • People with serious heart problems that significantly limit physical activity, or a confirmed diagnosis of coronary heart disease
  • People with a confirmed diagnosis of chronic obstructive pulmonary disease (COPD) or a history of asthma
  • People with severe liver disease (classified as Child-Pugh Class C — confirm with trial site)
  • People with advanced kidney disease who require dialysis
  • People with an active stomach ulcer or a bleeding disorder
  • People whose body mass index (BMI) is 18 or below, or 28 or above
  • People who regularly use painkillers over a long period of time
  • People who have taken anti-inflammatory pain medicines (NSAIDs, such as ibuprofen) within the past week
  • People who have a known allergy or sensitivity to anti-inflammatory pain medicines (NSAIDs)
  • People with a mental health or neurological condition that would prevent them from completing questionnaires, or a cognitive impairment affecting their legal capacity to consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8618616514088

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhejiang University
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The incidence of moderate to severe CRBD within 0-1 hour after surgery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov